<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28002441</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection.</ArticleTitle><Pagination><StartPage>e0168627</StartPage><MedlinePgn>e0168627</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0168627</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0168627</ELocationID><Abstract><AbstractText>Galectin-3, a chimeric type &#x3b2;-galactoside-binding protein, is known to modulate viral infection; however, its role in enterovirus 71 (EV71) infection has not been investigated. We generated galectin-3 null rhabdomyosarcoma (RD) cells and evaluated whether EV71 infection would be affected. In galectin-3 null cells, the released and intracellular EV71 viral loads were suppressed after 24 h of infection, and cell death rates were significantly lower, while cell proliferation remained unaltered. In addition, RD cells expressing a nonsynonymous genetic variant of galectin-3, rs4644 (LGALS3 +191C/A, P64H), produced lower virus titers than those with wild-type galectin-3 (C allele). To clarify whether the in vitro viral load reduction correlates with clinical severity, we enrolled children with laboratory-confirmed EV71 infection. Since hyperglycemia is an indicator of severe EV71 infection in children, 152 of 401 enrolled children had glucose examinations at admission, and 59 subjects had serum glucose levels &#x2265; 150 mg/dL. In comparison to the rs4644 AA genotype (2.2 &#xb1; 0.06 log10 mg/dL), serum glucose levels during EV71 infection were higher in patients with CC (2.4 &#xb1; 0.17 log10 mg/dL, p = 0.03) and CA (2.4 &#xb1; 0.15 log10 mg/dL, p = 0.02) genotypes, respectively. These findings suggest that the rs4644 AA genotype of galectin-3 might exert a protective effect. In summary, galectin-3 affects EV71 replication in our cellular model and its variant, rs4644, is associated with hyperglycemia in the clinical setting. The underlying mechanism and its potential therapeutic application warrant further investigation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wen-Chan</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ph.D. Program in Translational Medicine, National Taiwan University and Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hung-Lin</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Huan-Yuan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Kuan-Po</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>School of Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yungling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Li-Min</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Luan-Yin</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Fu-Tong</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, University of California Davis, Sacramento, California, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037502">Galectin 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037502" MajorTopicYN="N">Galectin 3</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="Y">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28002441</ArticleId><ArticleId IdType="pmc">PMC5176291</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0168627</ArticleId><ArticleId IdType="pii">PONE-D-16-38136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hsia SH, Wu CT, Chang JJ, Lin TY, Chung HT, Lin KL, et al. Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. Pediatr Infect Dis J. 2005;24: 331&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">15818293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassab S, Saghi T, Boyer A, Lafon M-E, Gruson D, Lina B, et al. Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerg Infect Dis. 2013;19: 1345&#x2013;1347. 10.3201/eid1908.130202</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1908.130202</ArticleId><ArticleId IdType="pmc">PMC3739532</ArticleId><ArticleId IdType="pubmed">23880543</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004;291: 222&#x2013;227. 10.1001/jama.291.2.222</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.2.222</ArticleId><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Shih WL, Yang SC, Yen TY, Lee JT, Huang YC, et al. Predicting severe enterovirus 71 infection: Age, comorbidity, and parental behavior matter. J Microbiol Immunol Infect. 2014; S1684&#x2013;1182(14)00243&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25678038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354: 1682&#x2013;1686. 10.1016/S0140-6736(99)04434-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Hsia SH, Huang YC, Chiu CH, Hsueh C, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis. 2002;34 Suppl 2: S52&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Chang IS, Chen WJ, Huang YC, Chen GW, Shih SR, et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics. 2008;122: 1271&#x2013;1276. 10.1542/peds.2007-3735</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3735</ArticleId><ArticleId IdType="pubmed">19047245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhao N, Su NL, Sun JL, Lv TG, Chen ZB. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis. 2012;44: 465&#x2013;469. 10.3109/00365548.2011.649490</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.649490</ArticleId><ArticleId IdType="pubmed">22263663</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv T, Li J, Han Z, Chen Z. Association of interleukin-17F gene polymorphism with enterovirus 71 encephalitis in patients with hand, foot, and mouth disease. Inflammation. 2013;36: 977&#x2013;981. 10.1007/s10753-013-9629-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-013-9629-8</ArticleId><ArticleId IdType="pubmed">23519962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou R, Zhang G, Li S, Wang W, Yuan J, Li J, et al. A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infection. Sci Rep. 2015;5: 18541 10.1038/srep18541</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep18541</ArticleId><ArticleId IdType="pmc">PMC4683517</ArticleId><ArticleId IdType="pubmed">26679744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HY, Weng IC, Hong MH, Liu FT. Galectins as bacterial sensors in the host innate response. Curr Opin Microbiol. 2014;17: 75&#x2013;81. 10.1016/j.mib.2013.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2013.11.006</ArticleId><ArticleId IdType="pubmed">24581696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu DK, Liu FT. Regulation of cellular homeostasis by galectins. Glycoconj J. 2004;19: 507&#x2013;515. 10.1023/B:GLYC.0000014080.95829.52</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:GLYC.0000014080.95829.52</ArticleId><ArticleId IdType="pubmed">14758074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiwaki K, Novak CM, Hsu DK, Liu FT, Levine JA. Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity (Silver Spring). 2007;15: 32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">17228029</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek JH, Kim SJ, Kang HG, Lee HW, Kim JH, Hwang KA, et al. Galectin-3 activates PPAR&#x3b3; and supports white adipose tissue formation and high-fat diet-induced obesity. Endocrinology. 2015;156: 147&#x2013;156. 10.1210/en.2014-1374</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2014-1374</ArticleId><ArticleId IdType="pubmed">25343273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer. 1999;81: 519&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">10225438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi&#xe8;che I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, et al. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology. 2005;332: 130&#x2013;144. 10.1016/j.virol.2004.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.11.009</ArticleId><ArticleId IdType="pubmed">15661146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SF, Tsao CH, Lin YT, Hsu DK, Chiang ML, Lo CH, et al. Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6. Glycobiology. 2014;24: 1022&#x2013;1035. 10.1093/glycob/cwu064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwu064</ArticleId><ArticleId IdType="pmc">PMC4181451</ArticleId><ArticleId IdType="pubmed">24996823</ArticleId></ArticleIdList></Reference><Reference><Citation>The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437: 1299&#x2013;1320. 10.1038/nature04226</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04226</ArticleId><ArticleId IdType="pmc">PMC1880871</ArticleId><ArticleId IdType="pubmed">16255080</ArticleId></ArticleIdList></Reference><Reference><Citation>Balan V, Nangia-Makker P, Schwartz AG, Jung YS, Tait L, Hogan V, et al. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): A Pilot Study. Cancer Res. 2008;68: 10045&#x2013;10050. 10.1158/0008-5472.CAN-08-3224</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-3224</ArticleId><ArticleId IdType="pmc">PMC2882172</ArticleId><ArticleId IdType="pubmed">19074869</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompet S, Jukema W, Mooijaart SP, Ford I, Stott DJ, Westendorp RG, et al. Genetic variation in galectin-3 gene associates with cognitive function at old age. Neurobiol Aging. 2012;33: 2232.e1&#x2013;2232.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22673112</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK, et al. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res. 2012;40: W117&#x2013;W122. 10.1093/nar/gks608</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks608</ArticleId><ArticleId IdType="pmc">PMC3394250</ArticleId><ArticleId IdType="pubmed">22693217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA. 1996;93: 6737&#x2013;6742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC39096</ArticleId><ArticleId IdType="pubmed">8692888</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Kao CL, Lu CY, Shao PL, Cheng AL, et al. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect. 2012;45: 96&#x2013;101. 10.1016/j.jmii.2011.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.09.025</ArticleId><ArticleId IdType="pubmed">22154997</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Lu CY, Cheng AL, Chang LY. Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study. Virol J. 2013;10: 209 10.1186/1743-422X-10-209</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-209</ArticleId><ArticleId IdType="pmc">PMC3717056</ArticleId><ArticleId IdType="pubmed">23800163</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Vega FM, Lazaruk KD, Rhodes MD, Wenz MH. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan&#xae; SNP Genotyping Assays and the SNPlex&#x2122; Genotyping System. Mutat Res. 2005;573: 111&#x2013;135. 10.1016/j.mrfmmm.2005.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2005.01.008</ArticleId><ArticleId IdType="pubmed">15829242</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen GQ, Abdullah KG, Wang QK. The TaqMan method for SNP genotyping. Methods Mol Biol. 2009;578: 293&#x2013;306. 10.1007/978-1-60327-411-1_19</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60327-411-1_19</ArticleId><ArticleId IdType="pubmed">19768602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, Huang YC, Yen TY, Hsia SH, Hsieh YC, Li CC, et al. The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study. BMC Infect Dis. 2014;14: 417 10.1186/1471-2334-14-417</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-417</ArticleId><ArticleId IdType="pmc">PMC4133623</ArticleId><ArticleId IdType="pubmed">25069383</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong H, Du N, Yang Y, Song L, Zhang W, Tien P. Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the pro-apoptotic protein Bax. J Virol. 2016; pii: JVI.01499-16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068536</ArticleId><ArticleId IdType="pubmed">27558414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He YQ, Yi LN, Zan H, Kung H-F, He ML. Viral kinetics of enterovirus 71 in human rhabdomyosarcoma cells. World J Gastroenterol. 2011;17: 4135&#x2013;4142. 10.3748/wjg.v17.i36.4135</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i36.4135</ArticleId><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ML, Weng SF, Kuo CH, Ho HY. Enterovirus 71 induces mitochondrial reactive oxygen species generation that is required for efficient replication. PLoS ONE. 2014;9: e113234 10.1371/journal.pone.0113234</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113234</ArticleId><ArticleId IdType="pmc">PMC4234665</ArticleId><ArticleId IdType="pubmed">25401329</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Finley RL, Raz A, Kim H-RC. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem. 2002;277: 15819&#x2013;15827. 10.1074/jbc.M200154200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200154200</ArticleId><ArticleId IdType="pubmed">11839755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukumori T, Oka N, Takenaka Y, Nangia-Makker P, Elsamman E, Kasai T, et al. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res. 2006;66: 3114&#x2013;3119. 10.1158/0008-5472.CAN-05-3750</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-3750</ArticleId><ArticleId IdType="pubmed">16540661</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobini C, Menini S, Ricci C, Fantauzzi CB, Scipioni A, Salvi L, et al. Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver. J Hepatol. 2011;54: 975&#x2013;983. 10.1016/j.jhep.2010.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2010.09.020</ArticleId><ArticleId IdType="pubmed">21145823</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolio TA, Collins FS. The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med. 2009;60: 443&#x2013;456. 10.1146/annurev.med.60.061907.093117</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.med.60.061907.093117</ArticleId><ArticleId IdType="pmc">PMC2717504</ArticleId><ArticleId IdType="pubmed">19630580</ArticleId></ArticleIdList></Reference><Reference><Citation>Soepandi PZ, Burhan E, Mangunnegoro H, Nawas A, Aditama TY, Partakusuma L, et al. Clinical Course of Avian Influenza A(H5N1) in Patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005&#x2013;2008. Chest. 2010;138: 665&#x2013;673. 10.1378/chest.09-2644</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-2644</ArticleId><ArticleId IdType="pmc">PMC7094603</ArticleId><ArticleId IdType="pubmed">20507944</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco RG, Tasker RC. Glycemic level in mechanically ventilated children with bronchiolitis. Pediatr Crit Care Med. 2007;8: 546&#x2013;550. 10.1097/01.PCC.0000288712.67749.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PCC.0000288712.67749.45</ArticleId><ArticleId IdType="pubmed">17906595</ArticleId></ArticleIdList></Reference><Reference><Citation>Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr. 2003;143: 142&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">14615713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho HY, Cheng ML, Weng SF, Chang L, Yeh TT, Shih SR, et al. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol. 2008;89: 2080&#x2013;2089. 10.1099/vir.0.2008/001404-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/001404-0</ArticleId><ArticleId IdType="pubmed">18753216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>